The following table provides an overview of the latest patents of Janssen Pharmaceutica Nv that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP4025188Jan 10, 2024Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations2
EP4025187Jan 3, 2024Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations2
EP3744326Dec 6, 2023Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters9
EP3609497Oct 12, 2022Combination Therapy For Prostate Cancer3
EP2234617Mar 31, 2021Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters20
EP3311374Jul 22, 2020Devices And Methods For Drug Administration And Mixing, And Training Of Proper Techniques Therefor1
EP3280416Apr 22, 2020Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters8
EP3087098Apr 8, 2020Anti-Vista Antibodies And Fragments2
EP2968221Jun 19, 2019Pharmaceutical Composition Of S-Ketamine Hydrochloride2
EP2451482May 1, 2019Combination Therapy For The Treatment Of Diabetes2